Elon Musk can finally begin testing his brain chip on humans. His company Neuralink, which focuses on brain-implant technology, announced that it has received approval from the US Food and Drug Administration (FDA) for its first human clinical trial.
This marks a significant milestone for Neuralink, as it had faced challenges in obtaining approval in the past.
Neuralink expressed its excitement about the FDA’s approval in a tweet, stating that it is an important first step towards helping many people.
However, the company did not provide specific details about the study, stating that recruitment has not yet begun and more information will be available soon.
“We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study! This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people. Recruitment is not yet open for our clinical trial. We’ll announce more information on this soon!,” Neuralink said in a tweet.
Elon Musk had previously said that brain implants could potentially address various conditions such as obesity, autism, depression, schizophrenia, and even enable functions like web browsing and telepathy.
Musk gained attention last year when he expressed confidence in the safety of the devices, even stating that he would be willing to implant them in his own children.
Follow Us on Facebook – @LadunLiadi; Instagram – @LadunLiadi; Twitter – @LadunLiadi; Youtube – @LadunLiadiTV for updates